KUALA LUMPUR, July 24 (Bernama) — Neuralstem Inc — a biopharmaceutical company developing novel treatments for nervous system diseases — announced some positive results in the treatment of Alzheimers disease. This was disclosed in the presentation of data at the Alzheimer’s Association International Conference in Chicago, Illinois.
